Innovation at Fred Hutch is supported by a suite of services and programs that accelerate discoveries and help speed their path from the research lab to the patient’s bedside. Our investigators and research partners have access to specialized facilities and equipment, integrated research centers, and powerful data science infrastructure and computational guidance.
Our cutting-edge shared resources include specialized equipment and unrivaled expertise to support basic, translational, clinical and public health studies.
We receive more than $345 million annually in research grants and contracts among independent U.S. research institutions.
We have a rich pipeline of inventions, programs and projects with promise for commercialization.
Fred Hutch is a leader in the commercialization of oncologic innovations, in partnership with pharma, biotech and venture capital partners.